Generic drugs will fuel revenue, Biovail chief says

Article Abstract:

According to its chairman, Eugene Melnyk, Biovail Corp. expects the sale of generic drugs to boost its revenue over the next couple of years.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Generic Drugs, Management, Melnyk, Eugene

---

Biovail building war chest

Article Abstract:

Biovail Corp. is issuing new common shares in one of the largest stock issues in Canada in the 2001 year. The company is issuing US$587.5 million in 12.5 million common shares.

Securities issued, listed, Securities

---

Bristol-Myers restates results as it erases $2.5-billion in sales

Article Abstract:

Bristol-Myers Squibb Co. restated its earnings for the 1999, 2000, and 2001 years due to questionable accounting practices. The restatement eliminated US$900 million in profit and $2.5 billion in revenues during those periods.

Company sales and earnings, Company earnings/profit, Bristol-Myers Squibb Co., BMY

Similar abstracts:

• Abstracts: U.S. giant Duke Energy grabs Westcoast in $3.5-billion (U.S.) deal. Power pays in Alberta auction
• Abstracts: Government should cut taxes by $61-billion, business lobby says. Report urges universal child tax benefit
• Abstracts: Protests greet delegates as food biosafety talks open in Montreal. Conference a 'win' for biotech giants
• Abstracts: With mine approval, Crystallex's value as target seen on rise. Environmentalists seek cruise rules
• Abstracts: Sears slashes profit forecast: Raises skepticism over holiday season. Gloomy Sears boss sees miserly consumers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.